LaVoieHealthScience Enters Inc. 5000 Hall of Fame as Five-Year Honoree

Demand for Integrated Investor and Public Relations Services from Health Science Innovators Drives 73% Three-Year Growth   

 

LaVoieHealthScience has been recognized on the prestigious Inc. 5000 list for the fifth time. This puts LaVoieHealthScience in the Inc. 5000 Hall of Fame – an honor bestowed on only 10% of listed companies.  Each year, Inc. magazine recognizes the fastest-growing private companies in the U.S., showcasing the immense level of development throughout the country. The list was released on August 15, 2018 and can be viewed here: https://www.inc.com/inc5000/index.html

“We are extremely proud to have achieved a spot on the Inc. 5000 for a third year in a row and fifth year overall – and entering the Hall of Fame is icing on the cake,” said Donna LaVoie, President and CEO of LaVoieHealthScience. “Our three-year growth rate of 73% is testament to our domain expertise and track record of providing strategic, integrated communications services to health and science clients worldwide. We’ve assembled a terrific roster of clients and a seasoned team of strategic advisors – positioning us well for further growth and momentum!”

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides public relations, investor relations and marketing and digital communications to build recognition and increase sales and value for health science innovations. The agency has received over 30 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients and was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies. LaVoieHealthScience represents leaders such as, Emmaus Life Sciences, Landos Biopharma, LEO Science & Tech Hub, Life Sciences Corridor, NewLink Genetics, Newron Pharmaceuticals, Origenis GmbH, PathMaker Neurosystems, Scioto Biosciences, Symbiotix Biotherapies, Triumvira Immunologics, XenoTherapeutics, Xontogeny LLC, and other emerging health and science companies.